Outset Medical, Inc. received an amended Schedule 13G/A from Durable Capital Partners reporting that it no longer beneficially owns any of the company’s common stock. The filing shows 0 shares beneficially owned and a 0.0% ownership of the class, with no voting or dispositive power reported.
The reporting person confirms its holdings are below 5% of the class and states that any securities referenced were acquired and held in the ordinary course of business, not for the purpose of changing or influencing control of Outset Medical.
Positive
None.
Negative
None.
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
SCHEDULE 13G
UNDER THE SECURITIES EXCHANGE ACT OF 1934
(Amendment No. 2)
Outset Medical, Inc.
(Name of Issuer)
Common Stock, par value of $0.001 per share
(Title of Class of Securities)
690145206
(CUSIP Number)
12/31/2025
(Date of Event Which Requires Filing of this Statement)
Check the appropriate box to designate the rule pursuant to which this Schedule is filed:
Rule 13d-1(b)
Rule 13d-1(c)
Rule 13d-1(d)
SCHEDULE 13G
CUSIP No.
690145206
1
Names of Reporting Persons
Durable Capital Partners LP
2
Check the appropriate box if a member of a Group (see instructions)
(a)
(b)
3
Sec Use Only
4
Citizenship or Place of Organization
DELAWARE
Number of Shares Beneficially Owned by Each Reporting Person With:
5
Sole Voting Power
0.00
6
Shared Voting Power
0.00
7
Sole Dispositive Power
0.00
8
Shared Dispositive Power
0.00
9
Aggregate Amount Beneficially Owned by Each Reporting Person
0.00
10
Check box if the aggregate amount in row (9) excludes certain shares (See Instructions)
11
Percent of class represented by amount in row (9)
0.0 %
12
Type of Reporting Person (See Instructions)
IA, PN
SCHEDULE 13G
Item 1.
(a)
Name of issuer:
Outset Medical, Inc.
(b)
Address of issuer's principal executive offices:
3052 Orchard Drive, San Jose, California 95134
Item 2.
(a)
Name of person filing:
Durable Capital Partners LP
(b)
Address or principal business office or, if none, residence:
4747 Bethesda Avenue, Suite 1002, Bethesda, Maryland 20814
(c)
Citizenship:
The Reporting Person is a limited partnership organized under the laws of the State of Delaware.
(d)
Title of class of securities:
Common Stock, par value of $0.001 per share
(e)
CUSIP No.:
690145206
Item 3.
If this statement is filed pursuant to §§ 240.13d-1(b) or 240.13d-2(b) or (c), check whether the person filing is a:
(a)
Broker or dealer registered under section 15 of the Act (15 U.S.C. 78o);
(b)
Bank as defined in section 3(a)(6) of the Act (15 U.S.C. 78c);
(c)
Insurance company as defined in section 3(a)(19) of the Act (15 U.S.C. 78c);
(d)
Investment company registered under section 8 of the Investment Company Act of 1940 (15 U.S.C. 80a-8);
(e)
An investment adviser in accordance with § 240.13d-1(b)(1)(ii)(E);
(f)
An employee benefit plan or endowment fund in accordance with § 240.13d-1(b)(1)(ii)(F);
(g)
A parent holding company or control person in accordance with § 240.13d-1(b)(1)(ii)(G);
(h)
A savings associations as defined in Section 3(b) of the Federal Deposit Insurance Act (12 U.S.C. 1813);
(i)
A church plan that is excluded from the definition of an investment company under section 3(c)(14) of the Investment Company Act of 1940 (15 U.S.C. 80a-3);
(j)
A non-U.S. institution in accordance with § 240.13d-1(b)(1)(ii)(J). If filing as a non-U.S. institution in accordance with § 240.13d-1(b)(1)(ii)(J),
please specify the type of institution:
(k)
Group, in accordance with Rule 240.13d-1(b)(1)(ii)(K).
Item 4.
Ownership
(a)
Amount beneficially owned:
The information required by this item with respect to the Reporting Person is set forth in Rows 5 through 9 and 11 of the cover page to this Schedule 13G. Durable Capital Master Fund LP directly holds 0 shares of Class A Common Stock, $0.0001 per share (the "Shares"). The Reporting Person, as the investment adviser to Durable Capital Master Fund LP, has sole power to direct the vote and disposition of the Shares. Durable Capital Partners GP LLC ("Durable GP") is the general partner of the Reporting Person, and Henry Ellenbogen is the chief investment officer of the Reporting Person and the managing member of Durable GP.
(b)
Percent of class:
0.0 %
(c)
Number of shares as to which the person has:
(i) Sole power to vote or to direct the vote:
0
(ii) Shared power to vote or to direct the vote:
0
(iii) Sole power to dispose or to direct the disposition of:
0
(iv) Shared power to dispose or to direct the disposition of:
0
Item 5.
Ownership of 5 Percent or Less of a Class.
Ownership of 5 percent or less of a class
Item 6.
Ownership of more than 5 Percent on Behalf of Another Person.
If any other person is known to have the right to receive or the power to direct the receipt of dividends from, or the proceeds from the sale of, such securities, a statement to that effect should be included in response to this item and, if such interest relates to more than 5 percent of the class, such person should be identified. A listing of the shareholders of an investment company registered under the Investment Company Act of 1940 or the beneficiaries of employee benefit plan, pension fund or endowment fund is not required.
See disclosure of relationships among parties under Item 4. The economic benefits of the Shares are shared based on agreements among the parties.
Item 7.
Identification and Classification of the Subsidiary Which Acquired the Security Being Reported on by the Parent Holding Company or Control Person.
If a parent holding company has filed this schedule, pursuant to Rule 13d-1(b)(ii)(G), so indicate under Item 3(g) and attach an exhibit stating the identity and the Item 3 classification of the relevant subsidiary. If a parent holding company has filed this schedule pursuant to Rule 13d-1(c) or Rule 13d-1(d), attach an exhibit stating the identification of the relevant subsidiary.
See control and Shares holding disclosure in Item 4.
Item 8.
Identification and Classification of Members of the Group.
Not Applicable
Item 9.
Notice of Dissolution of Group.
Not Applicable
Item 10.
Certifications:
By signing below I certify that, to the best of my knowledge and belief, the securities referred to above were acquired and are held in the ordinary course of business and were not acquired and are not held for the purpose of or with the effect of changing or influencing the control of the issuer of the securities and were not acquired and are not held in connection with or as a participant in any transaction having that purpose or effect, other than activities solely in connection with a nomination under ?? 240.14a-11.
SIGNATURE
After reasonable inquiry and to the best of my knowledge and belief, I certify that the information set forth in this statement is true, complete and correct.
What does Durable Capital Partners report in this Schedule 13G/A for OM?
Durable Capital Partners reports beneficial ownership of 0 shares of Outset Medical common stock, representing 0.0% of the class. The filing indicates it has no sole or shared voting or dispositive power over any Outset Medical shares.
Why did Durable Capital Partners file an amended Schedule 13G/A for Outset Medical (OM)?
The amended Schedule 13G/A reflects that Durable Capital Partners’ beneficial ownership in Outset Medical common stock has fallen to 5 percent or less. The filing now shows 0 shares and 0.0% ownership, triggering updated disclosure of its reduced position.
How much of Outset Medical’s common stock does Durable Capital Partners now own?
Durable Capital Partners reports owning 0 shares of Outset Medical common stock and a 0.0% interest in the class. The cover information shows zero sole or shared voting power and zero sole or shared dispositive power over any shares.
What does ‘ownership of 5 percent or less of a class’ mean in this OM filing?
The filing’s Item 5 states ownership of 5 percent or less of Outset Medical’s common stock. In this case, Durable Capital Partners reports 0 shares and 0.0% of the class, confirming it is no longer a 5% beneficial owner.
Is Durable Capital Partners seeking to influence control of Outset Medical (OM)?
No. The certification states the securities were acquired and are held in the ordinary course of business and not for changing or influencing control of Outset Medical, nor in connection with any transaction having that purpose or effect.